A randomized comparative study on rectal versus oral Diclofenac for perineal pain relief following episiotomy repair in a tertiary hospital - Trial PACTR202308864630455
Access comprehensive clinical trial information for PACTR202308864630455 through Pure Global AI's free database. This Phase 3 trial is sponsored by Princeba Tamunobelema Amachree and is currently Not yet recruiting. The study focuses on Obstetrics and Gynecology.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Princeba Tamunobelema Amachree
Princeb Tamunobelema Amachree
Timeline & Enrollment
Phase 3
Jan 01, 1900
Jan 01, 1900
Summary
Perineal pain following episiotomy repair is a common complaint after vaginal delivery. It usually results from incision site inflammation, tissue oedema and spasms of the perineal muscles. It may be severe, especially in the immediate postpartum period requiring the use of analgesics. Diclofenac is a non-steroidal anti-inflammatory drug commonly used in pain relief as it controls inflammation and inhibits chemical mediators of pain. The aim is to determine the effectiveness rectal versus oral Diclofenac in the management of pain following episiotomy repair.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202308864630455
Non-Device Trial